Combatting misconceptions in glaucoma testing

News
Video

Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.

Robert L. Stamper, OD, addressed optometrists about the nuances of glaucoma testing during the recent Glaucoma 3260 meeting.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

What do you wish more optometrists knew about glaucoma?

Robert L. Stamper, MD: I'd say the variability in presentation, the racial differences in susceptibility to glaucoma, and I would say the fact that glaucoma, by and large, is a slowly progressive disease, and we don't always have to make decisions in the moment, that we can wait and see how it evolves, to see if it's progressing before we initiate or escalatetreatment.

What are the most common misconceptions of glaucoma testing?

Stamper: The most common misconceptions are the infallibility of our diagnostic equipment, which kind of relates back to not having to make a momentary decision, except in extreme, extreme situations. But for the most part, with chronic glaucoma, often our machines aren't programmed to take into account ethnic and racial differences. They're based, often, on a small number of patients to develop a normative database, so what the machine prints out as being "abnormal" may not, in fact, be "abnormal," may just be a product of some genetic difference between 1 person and another. I think one should, again, except in far advanced situations, one has the ability to repeat the examination, make sure that you're where you're comfortable with the results of testing.

Recent Videos
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
© 2025 MJH Life Sciences

All rights reserved.